These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 24929493)
1. Detection and staging of esophageal cancers within Barrett's esophagus is improved by assessment in specialized Barrett's units. Cameron GR; Jayasekera CS; Williams R; Macrae FA; Desmond PV; Taylor AC Gastrointest Endosc; 2014 Dec; 80(6):971-83.e1. PubMed ID: 24929493 [TBL] [Abstract][Full Text] [Related]
2. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience. Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526 [TBL] [Abstract][Full Text] [Related]
3. Added value of narrow band imaging and confocal laser endomicroscopy in detecting Barrett's esophagus neoplasia. Jayasekera C; Taylor AC; Desmond PV; Macrae F; Williams R Endoscopy; 2012 Dec; 44(12):1089-95. PubMed ID: 23188660 [TBL] [Abstract][Full Text] [Related]
4. Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett's oesophagus: a prospective, international, randomised controlled trial. Sharma P; Hawes RH; Bansal A; Gupta N; Curvers W; Rastogi A; Singh M; Hall M; Mathur SC; Wani SB; Hoffman B; Gaddam S; Fockens P; Bergman JJ Gut; 2013 Jan; 62(1):15-21. PubMed ID: 22315471 [TBL] [Abstract][Full Text] [Related]
5. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management. Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948 [TBL] [Abstract][Full Text] [Related]
6. Trimodal imaging-assisted endoscopic mucosal resection of early Barrett's neoplasia. Thomas T; Singh R; Ragunath K Surg Endosc; 2009 Jul; 23(7):1609-13. PubMed ID: 19296171 [TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854 [TBL] [Abstract][Full Text] [Related]
8. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus. Neuhaus H; Terheggen G; Rutz EM; Vieth M; Schumacher B Endoscopy; 2012 Dec; 44(12):1105-13. PubMed ID: 22968641 [TBL] [Abstract][Full Text] [Related]
9. Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett's Esophagus. Wolfsen HC; Crook JE; Krishna M; Achem SR; Devault KR; Bouras EP; Loeb DS; Stark ME; Woodward TA; Hemminger LL; Cayer FK; Wallace MB Gastroenterology; 2008 Jul; 135(1):24-31. PubMed ID: 18442484 [TBL] [Abstract][Full Text] [Related]
10. Endoscopic mucosal resection results in change of histologic diagnosis in Barrett's esophagus patients with visible and flat neoplasia: a multicenter cohort study. Wani S; Abrams J; Edmundowicz SA; Gaddam S; Hovis CE; Green D; Gupta N; Higbee A; Bansal A; Rastogi A; Early D; Lightdale CJ; Sharma P Dig Dis Sci; 2013 Jun; 58(6):1703-9. PubMed ID: 23633158 [TBL] [Abstract][Full Text] [Related]
11. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus. Pacifico RJ; Wang KK; Wongkeesong LM; Buttar NS; Lutzke LS Clin Gastroenterol Hepatol; 2003 Jul; 1(4):252-7. PubMed ID: 15017665 [TBL] [Abstract][Full Text] [Related]
12. Early esophageal cancer in Europe: endoscopic treatment by endoscopic submucosal dissection. Probst A; Aust D; Märkl B; Anthuber M; Messmann H Endoscopy; 2015 Feb; 47(2):113-21. PubMed ID: 25479563 [TBL] [Abstract][Full Text] [Related]
13. Occurrence of invasive cancer after endoscopic treatment of Barrett's esophagus with high-grade dysplasia and intramucosal cancer in physiologically fit patients: time for a review of surveillance and treatment guidelines. Templeton A; Bodnar A; Gan SI; Irani S; Ross A; Low D Gastrointest Endosc; 2014 May; 79(5):839-44. PubMed ID: 24447341 [No Abstract] [Full Text] [Related]
14. Development and Validation of a Classification System to Identify High-Grade Dysplasia and Esophageal Adenocarcinoma in Barrett's Esophagus Using Narrow-Band Imaging. Sharma P; Bergman JJ; Goda K; Kato M; Messmann H; Alsop BR; Gupta N; Vennalaganti P; Hall M; Konda V; Koons A; Penner O; Goldblum JR; Waxman I Gastroenterology; 2016 Mar; 150(3):591-8. PubMed ID: 26627609 [TBL] [Abstract][Full Text] [Related]
15. Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. Schembre DB; Huang JL; Lin OS; Cantone N; Low DE Gastrointest Endosc; 2008 Apr; 67(4):595-601. PubMed ID: 18279860 [TBL] [Abstract][Full Text] [Related]
16. Low prevalence of submucosal invasive carcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in Barrett's esophagus: a 20-year experience. Wang VS; Hornick JL; Sepulveda JA; Mauer R; Poneros JM Gastrointest Endosc; 2009 Apr; 69(4):777-83. PubMed ID: 19136106 [TBL] [Abstract][Full Text] [Related]